CNS Therapeutics' Series C Round

CNS Therapeutics raised a round of funding on August 20, 2009.

CNS Therapeutics develops and markets safe, high-quality pharmaceuticals for site-specific delivery to the central nervous system to treat neurological disorders and chronic pain. In addition to its F…

Articles about CNS Therapeutics' Series C Round: